M&A news

Veeva Systems Acquires Copli to

Copli acquired by Veeva Systems

AcquisitionProfessional ServicesDK

Get the full Copli company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Copli logo
Acquired

Copli

DenmarkProfessional Services

Undisclosed amount

June 23, 2026

Veeva Systems logo
Acquirer

Veeva Systems

Software Development

Veeva Systems has acquired Copli, an AI-powered Medical, Legal, and Regulatory (MLR) review platform, for an undisclosed amount. This acquisition brings Copli's advanced artificial intelligence capabilities directly into Veeva's ecosystem, aiming to streamline and accelerate compliance processes for life sciences companies worldwide.

Copli specializes in performing end-to-end MLR reviews with human-level accuracy, identifying medical, claims, regulatory, and brand risks across various material types, including digital visual aids, emails, presentations, and websites. Its technology is tailored to any language and local regulation globally, providing real-time, actionable insights. A key feature is its automatic claim anchoring to approved references within Veeva Vault PromoMats, a testament to its existing seamless integration as an official Veeva AI Partner. Copli also facilitates global-to-local compliance checks against country-specific regulations, significantly reducing localization and review cycles.

The strategic rationale behind this acquisition centers on enhancing Veeva's comprehensive suite of cloud software for the life sciences industry. By integrating Copli's AI MLR reviewer, Veeva aims to offer its customers an even more efficient and accurate solution for content compliance. This move is expected to cut manual review work, boost review speed, and ensure complete regulatory adherence from the first draft to final approval, thereby accelerating time-to-market for critical life sciences content.

This acquisition underscores Veeva's commitment to leveraging artificial intelligence to solve complex industry challenges. The combination of Veeva's established platform and Copli's specialized AI technology is anticipated to deliver a more robust and intelligent compliance solution. The unified entity is poised to further innovate in the regulatory review space, providing life sciences companies with advanced tools to navigate an increasingly complex global regulatory landscape more effectively and with greater confidence.

No buying signals identified yet.

Unlock GTM signals

Discover Copli's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Copli.

Unlock decision-makers